Evidence map›Paper›PMID 39285586›Full record

ArticleCancer communications (London, England)2024

Local TSH/TSHR signaling promotes CD8

Sisi Zeng, Huiling Hu, Zhiyang Li, Qi Hu, Rong Shen, Mingzhou Li, Yunshi Liang, Zuokang Mao, Yandong Zhang, Wanqi Zhan and 12 more

Abstract read
In one paragraph

Article in Cancer communications (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Sisi ZengDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Huiling HuDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Zhiyang LiDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Qi HuDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Rong ShenDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Mingzhou LiDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Yunshi LiangDepartment of Pathology, Guangzhou First People's Hospital, Guangzhou, Guangdong, P. R. China.
Zuokang MaoDepartment of Hepatobiliary Surgery, The Seventh Affiliated Hospital, Southern Medical University, Foshan, Guangdong, P. R. China.
Yandong ZhangDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Wanqi ZhanDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Qin ZhuDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Feifei WangDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Jianbiao XiaoDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Bohan XuDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Guanglong LiuDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Yanan WangDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Bingsong LiDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Shaowan XuDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Zhaowen ZhangDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Ceng ZhangDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Zhizhang WangDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Li LiangDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.ORCID 0000-0003-2424-4926

Funding

National Key Research and Development Program of China 2021YFF1201004National Natural Science Foundation of China 32270926National Natural Science Foundation of China 81802306National Natural Science Foundation of China 81872041National Natural Science Foundation of China 81903002National Natural Science Foundation of China 82071742National Natural Science Foundation of China 82273358Natural Science Foundation of Guangdong Province 2019A1515012196Natural Science Foundation of Guangdong Province 2022A1515012059
6 · The paper itself

Abstract

backgroundDysfunction of CD8

methodsTSHR expression levels in CD8

resultsTSHR was highly expressed in cancer cells and CD8

conclusionsThe present findings highlighted the role of endogenous TSH/TSHR signaling in CD8

Indexed as

CD8-Positive T-LymphocytesColorectal NeoplasmsReceptors, ThyrotropinSignal TransductionThyrotropinTumor MicroenvironmentAnimalsCell Line, TumorHumansMiceT-Cell ExhaustionTumor EscapeReceptors, ThyrotropinThyrotropinCD8+ T cell exhaustionColorectal carcinomaImmune evasionThyroid stimulating hormoneThyroid stimulating hormone receptor

Identifiers

PMID39285586
PMCPMC11570765

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.